BioCentury | Aug 26, 2020
Deals

Aug. 25 Quick Takes: A slew of private financings led by Connect’s $115M series C; plus BMS-Forbius, Takeda deals, Bio-Thera-BeiGene and adds to HKSE, NASDAQ queues

...respiratory syncytial virus (RSV). CR-CP Life Sciences Fund led the round, with participation from Andera Partners, Brace Pharma...
BioCentury | Aug 13, 2020
Finance

F2G raises $60.8M to get new class of antifungal to market

...CEO, and Tony Kennedy is chief scientific and development officer.Existing investors Novo Holdings, Morningside Ventures, Brace Pharma...
BioCentury | Jul 22, 2020
Finance

July 21 Quick Takes: Royalty to reap risdiplam royalties; plus CureVac, Antengene, Citrine, Verona, Novartis, Amicus, Aslan, SAB, Gain

...from undisclosed investors and appointed Eric Richman as CEO. He was a venture partner at Brace Pharma...
BioCentury | May 21, 2020
Finance

HotSpot heads for clinic with $65M series B round to develop allosteric modulators

...B funding, which included new investors Tekla Capital Management, MRL Ventures Fund, Solasta Ventures and Brace Pharma...
BioCentury | Dec 19, 2019
Financial News

Versant’s Pipeline raises $30M series B for regenerative therapies

...myelin around the axon to address the root cause of MS. Sectoral’s Stefan Larson and Brace Pharma...
BioCentury | Nov 13, 2019
Finance

Conjugate company Avidity preps for first dystrophy study with $100M series C

...as well as returning investors Alethea Capital, Alexandria Venture Investments, Boxer Capital of Tavistock Group, Brace Pharma...
BioCentury | Apr 22, 2019
Company News

Lilly pays $35M up front to partner with Avidity on oligo conjugates

...million in venture funding. Its investors include Takeda Ventures, Alethea Capital, Alexandria Real Estate Equities, Brace Pharma...
BioCentury | Aug 3, 2018
Financial News

ReViral raises $55M series B

...the round was fellow new investor Perceptive Advisors and existing investors Andera Partners, OrbiMed and Brace Pharma...
BioCentury | Aug 1, 2018
Finance

Safety goes (Re)Viral

...and saw participation from new investor Perceptive Advisors and existing investors Andera Partners, OrbiMed and Brace Pharma...
BioCentury | Aug 1, 2018
Financial News

ReViral raises $55M series B

...the round was fellow new investor Perceptive Advisors and existing investors Andera Partners, OrbiMed and Brace Pharma...
Items per page:
1 - 10 of 33
BioCentury | Aug 26, 2020
Deals

Aug. 25 Quick Takes: A slew of private financings led by Connect’s $115M series C; plus BMS-Forbius, Takeda deals, Bio-Thera-BeiGene and adds to HKSE, NASDAQ queues

...respiratory syncytial virus (RSV). CR-CP Life Sciences Fund led the round, with participation from Andera Partners, Brace Pharma...
BioCentury | Aug 13, 2020
Finance

F2G raises $60.8M to get new class of antifungal to market

...CEO, and Tony Kennedy is chief scientific and development officer.Existing investors Novo Holdings, Morningside Ventures, Brace Pharma...
BioCentury | Jul 22, 2020
Finance

July 21 Quick Takes: Royalty to reap risdiplam royalties; plus CureVac, Antengene, Citrine, Verona, Novartis, Amicus, Aslan, SAB, Gain

...from undisclosed investors and appointed Eric Richman as CEO. He was a venture partner at Brace Pharma...
BioCentury | May 21, 2020
Finance

HotSpot heads for clinic with $65M series B round to develop allosteric modulators

...B funding, which included new investors Tekla Capital Management, MRL Ventures Fund, Solasta Ventures and Brace Pharma...
BioCentury | Dec 19, 2019
Financial News

Versant’s Pipeline raises $30M series B for regenerative therapies

...myelin around the axon to address the root cause of MS. Sectoral’s Stefan Larson and Brace Pharma...
BioCentury | Nov 13, 2019
Finance

Conjugate company Avidity preps for first dystrophy study with $100M series C

...as well as returning investors Alethea Capital, Alexandria Venture Investments, Boxer Capital of Tavistock Group, Brace Pharma...
BioCentury | Apr 22, 2019
Company News

Lilly pays $35M up front to partner with Avidity on oligo conjugates

...million in venture funding. Its investors include Takeda Ventures, Alethea Capital, Alexandria Real Estate Equities, Brace Pharma...
BioCentury | Aug 3, 2018
Financial News

ReViral raises $55M series B

...the round was fellow new investor Perceptive Advisors and existing investors Andera Partners, OrbiMed and Brace Pharma...
BioCentury | Aug 1, 2018
Finance

Safety goes (Re)Viral

...and saw participation from new investor Perceptive Advisors and existing investors Andera Partners, OrbiMed and Brace Pharma...
BioCentury | Aug 1, 2018
Financial News

ReViral raises $55M series B

...the round was fellow new investor Perceptive Advisors and existing investors Andera Partners, OrbiMed and Brace Pharma...
Items per page:
1 - 10 of 33